HT-29 is an adherent epithelial cell line isolated from a primary tumor obtained from a patient with colorectal adenocarcinoma. These cells express characteristics of mature intestinal cells and …

The human colon adenocarcinoma cell line HT29, is not only used to study the biology of human colon cancers, but it is receiving special interest in studies focused on food digestion and bioavailability due to the ability to express characteristics of mature intestinal cells.

HT-29 is a human colorectal cancer cell line with a wide range of cancer and toxicology research applications. Such as, these cells are sensitive to standard chemotherapeutic treatments against colorectal cancer.

The human colon adenocarcinoma cell line HT29, is not only used to study the biology of human colon cancers, but it is receiving special interest in studies focused on food digestion and bioavailability due to the ability to express characteristics of mature intestinal cells.

Dec 19, 2024 · Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 809. Population: Caucasian. Virology: Not susceptible to infection by SARS …

HT-29 is a human colorectal adenocarcinoma cell line with epithelial morphology. These cells are sensitive to the chemotherapeutic drugs 5-fluorouracil and oxaliplatin, which are standard treatment options for colorectal cancer.

HT-29 (人结肠癌细胞) (STR鉴定正确) ￥1600. 现单独购买该产品也可享受限时优惠价！ 细胞培养最优解！ HT-29细胞是由J·Fogh在1964年用移植培养方法和含15%FBS的F12培养液从原发性肿瘤分离的；近来，已建株的培养细胞用含相同血清McCoy's5A培液培养。 HT-29细胞在裸鼠中致瘤，也能在类固醇处理的地鼠中致瘤。 HT-29细胞合成IgA、CEA、蛋白绑定TGF-β的分泌成分 …

It is a selective topoisomerase I inhibitor that is effective against many cancers, such as colorectal cancer. Previously, we successfully formulated a magnetic nanocarrier-conjugated CPT with β-cyclodextrin and iron NPs (Fe 3 O 4) cross-linked using EDTA (CPT-CEF).

STR analysis according to the global standard ANSI/ATCC ASN-0002.1-2021 (2021) resulted in an authentic STR profile of the reference STR database.

HT29 cells harvested from tissue culture flasks are implanted into the subcutaneous space of the left flank of the mice. Resulting tumors are monitored by calipering twice weekly. Animal weights are measured three times weekly. Animal behaviour is monitored daily.